Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
New study links kidney cancer to increased risk of dangerous blood clotting
April 22, 2014
Dr.
Marc Carrier
has published a
study
in the
Journal of Thrombosis and Haemostasis
that identifies an increased risk of developing dangerous blood clotting in the veins (venous thromboembolism, or VTE) of people who have had surgery for kidney cancer (renal cell carcinoma) but whose tumours could not be fully removed because of spread to the veins (tumour thrombus). In the first study of its kind, Dr. Carrier and his team found that such patients are eight times more likely to develop VTE than cancer patients whose tumor did not move to the veins. These findings suggest that these cancer patients with residual tumor thrombus may benefit from drugs that reduce blood clotting as a way to prevent VTE.
Funders:
The Ottawa Hospital Foundation and The University of Ottawa
About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.
Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)
padmoore@ohri.ca